Merck on Thursday announced a ground-breaking £90m ($148.6m) partnership with the Wellcome Trust to develop vaccines for the developing world.

The venture will combine the ideas of academic scientists with the technical experience of researchers from pharmaceutical companies in an effort to develop affordable and effective vaccines. The MSD Wellcome Trust Hilleman Laboratories will be based in India with 60 staff.